Mechanism of action of the hepatitis B and D virus cell entry inhibitor bulevirtide deciphered

Over 12 million people worldwide suffer from a chronic infection with the hepatitis D virus. This most severe viral liver disease is associated with a high risk of dying from liver cirrhosis and liver cancer. It is caused by the hepatitis D virus (HDV), which uses the surface proteins of the hepatitis B virus (HBV) as a vehicle to specifically enter liver cells via a protein in the cell membrane — the bile salt transporter protein NTCP.

Leave a Reply